💉 365 injections a year → 52 injections a year. Awiqli® (i…

💉 365 injections a year → 52 injections a year.

Awiqli® (insulin icodec) is a once-weekly basal insulin designed to reduce injection frequency for adults living with diabetes.

A significant step forward in simplifying insulin therapy while maintaining effective glycaemic control.

📖 Learn more about the science, evidence and clinical considerations behind once-weekly insulin therapy:

www.ema.europa.eu

Awiqli | European Medicines Agency (EMA)

Awiqli is a medicine used to treat adults with diabetes. It contains the active substance insulin icodec, a long-acting insulin.

0 likes · 0 comments · 5 views